NICOLA HANANIA to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications NICOLA HANANIA has written about Randomized Controlled Trials as Topic.
Connection Strength
0.461
-
Effect of Age on Efficacy and Safety of Fluticasone Furoate/Vilanterol (FF/VI), Umeclidinium (UMEC), and UMEC + FF/VI in Patients with Chronic Obstructive Pulmonary Disease: Analyses of Five Randomized Clinical Trials. Int J Chron Obstruct Pulmon Dis. 2021; 16:1925-1938.
Score: 0.125
-
Pooled subpopulation analyses of the effects of roflumilast on exacerbations and lung function in COPD. Respir Med. 2014 Feb; 108(2):366-75.
Score: 0.073
-
Targeting IgE in asthma. Curr Opin Pulm Med. 2012 Jan; 18(1):1-5.
Score: 0.065
-
Treatments for COPD. Respir Med. 2005 Dec; 99 Suppl B:S28-40.
Score: 0.042
-
Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials. Lancet Respir Med. 2025 Jun; 13(6):505-516.
Score: 0.041
-
Impact of doxofylline compared to theophylline in asthma: A pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomized studies (DOROTHEO 1 and DOROTHEO 2). Pulm Pharmacol Ther. 2018 Dec; 53:20-26.
Score: 0.026
-
Care pathways for the selection of a biologic in severe asthma. Eur Respir J. 2017 12; 50(6).
Score: 0.024
-
Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis. COPD. 2017 Oct; 14(5):552-563.
Score: 0.024
-
Persistence of effectiveness of bronchial thermoplasty in patients with severe asthma. Ann Allergy Asthma Immunol. 2011 Jul; 107(1):65-70.
Score: 0.015
-
Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease. Adv Ther. 2009 Nov; 26(11):1024-34.
Score: 0.014
-
It's about time--directing our attention toward modifying the course of COPD. Respir Med. 2008 Jun; 102 Suppl 1:S37-48.
Score: 0.013